PB Fintech stock drops 10% in two sessions after announcing a Rs 696 crore investment in subsidiary PB Healthcare Services.
Investment aims to expand operations but requires shareholder approval via a postal ballot.
Stock trades below key SMAs; RSI at 36.2, signaling weak technicals.
Despite a 37% YTD decline, stock gained 135% in two years; analysts maintain a 'Hold' rating.
Comments
Post a Comment